Aim of study
This study investigated the hepatoprotective effects of BT, its chemical composition, correlations with target components, and mechanisms underlying acetaminophen (APAP)-induced liver injury.
Materials and methods
APAP-induced injury models were established using HepG2 cells and C57BL/6 mice. Cell viability, cytotoxicity, levels of pro-inflammatory cytokines (IL-1β, TNF-α), apoptosis, and proliferation were evaluated through CCK-8, ELISA, flow cytometry, and EDU staining. In C57BL/6 mice model, measurements included body weight, liver index, serum levels of transaminases (ALT, AST) and ALP, and hepatic histopathology via H&E staining. Key signaling pathways were identified through RNA sequencing, KEGG/GO enrichment analyses, RT-qPCR, and Western blotting (WB). Chemical components of BT were analyzed using UHPLC-QE-Orbitrap HRMS, with subsequent molecular docking and dynamics simulations for studying component-target interactions.
Results
The findings indicated that BT (25/100 μg/mL in cells; 50/100/200 mg/kg in C57BL/6 mice model) significantly enhanced cell viability, reduced inflammatory cytokine levels and apoptosis, mitigated liver damage, and lowered serum enzyme levels in a dose-dependent manner. The B-cell receptor (BCR) signaling pathway emerged as crucial based on RNA sequencing, which was confirmed by WB and RT-qPCR. Analysis revealed forty-five compounds in BT, with kaempferitrin demonstrating consistent binding to LYN kinase (a key BCR pathway target) throughout 100 ns simulations.
Conclusions
In summary, BT demonstrates substantial hepatoprotective effects, potentially by suppressing the BCR signaling pathway, with kaempferitrin identified as a critical bioactive component targeting LYN kinase.
扫码关注我们
求助内容:
应助结果提醒方式:
